Carola Vinuesa’s research aims to unravel the complex interaction of cells and molecules that regulate the production of potent, long-lasting antibody responses and to identify genetic abnormalities that interfere with this process and contribute to the development of autoimmunity.
Her group has identified genes, cell types and checkpoints important to prevent autoantibody-mediated diseases. Her team is also working towards connecting genetic variation in humans to autoimmune disease with the goal of identifying more targeted treatments. She directs the Centre for Personalised immunology (CPI), an NHMRC Centre for Research Excellence that is sequencing whole genomes from patients with immune-mediated diseases to uncover mutations that cause disease. She also co-directs the China Australia Centre for Personalised Immunology (CACPI) based in Shanghai Renji Hospital (Jiaotong University). The ultimate aim of her research is to understand autoimmune disease pathogenesis, refine diagnosis and develop improved approaches to therapy.
Carola Vinuesa was born in Spain and obtained a medical degree at the University Autonoma of Madrid. She undertook specialist clinical training in the UK and in 2000 was awarded a PhD by the University of Birmingham. A year later she was the recipient of a Wellcome Trust International Travelling prize Fellowship to do postdoctoral work at The John Curtin School for Medical Research in The Australian National University. Since 2006 she has been a group leader. She has been the recipient of several prestigious awards including the Science Minister’s Prize for Life Scientist of the year (2008), the Gottschalk Medal of the Australian Academy of Sciences (2009). In 2015, she was elected as a Fellow of the Australian Academy of Science. She is currently Professor of Immunology at the Australian National University and Director of the Centre for Personalised Immunology (CPI), an NHMRC Centre for Research Excellence.